|
시장보고서
상품코드
1968032
HLA 타이핑 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global HLA Typing Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
HLA 타이핑 시장 규모는 2025년 13억 9,000만 달러에서 2026-2034년에 CAGR 7.04%로 성장하며, 2034년에는 25억 7,000만 달러에 달할 것으로 예측되고 있습니다.
세계 HLA타이핑 시장은 장기이식 수술 증가와 조직적합성 검사에 대한 인식이 높아짐에 따라 괄목할 만한 성장세를 보이고 있습니다. 인간 백혈구 항원(HLA) 타이핑은 골수 이식 및 고형 장기 이식에서 매우 중요한 역할을 합니다. 장기 부전을 유발하는 만성질환 증가로 인해 전 세계에서 정확하고 진보된 HLA 검사 솔루션에 대한 수요가 증가하고 있습니다.
주요 성장 요인으로는 차세대 염기서열 분석(NGS), PCR 기반 검사법 등 분자진단 기술의 발전을 들 수 있습니다. 기증자 등록제도 확대와 이식 프로그램에 대한 정부 지원도 시장 성장에 기여하고 있습니다. 면역학 및 맞춤의료 분야의 연구는 임상 및 연구 환경에서 정밀한 HLA 타이핑에 대한 수요를 더욱 강화하고 있습니다.
앞으로의 성장은 기술 혁신, 검사실 자동화, 전 세계 이식 건수 증가에 의해 주도될 것으로 예측됩니다. 신흥 시장에서는 의료 인프라에 대한 투자가 진행되고 있으며, 새로운 기회가 창출될 것으로 예측됩니다. 또한 데이터 분석의 정확도 향상을 위한 바이오인포매틱스 툴의 통합으로 검사의 정확성과 효율성이 향상되어 지속적인 시장 확대를 지원할 것입니다.
목차
제1장 서론
제2장 개요
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 HLA 타이핑 시장 : 제품별
제5장 세계의 HLA 타이핑 시장 : 용도별
제6장 세계의 HLA 타이핑 시장 : 방법별
제7장 세계의 HLA 타이핑 시장 : 최종사용자별
제8장 세계의 HLA 타이핑 시장 : 지역별
제9장 경쟁 구도
제10장 기업 개요
KSA 26.03.25The HLA Typing Market size is expected to reach USD 2.57 Billion in 2034 from USD 1.39 Billion (2025) growing at a CAGR of 7.04% during 2026-2034.
The Global HLA Typing Market is witnessing strong growth due to increasing organ transplantation procedures and rising awareness about tissue compatibility testing. Human Leukocyte Antigen (HLA) typing plays a critical role in bone marrow and solid organ transplants. Growing cases of chronic diseases leading to organ failure are boosting demand for accurate and advanced HLA testing solutions worldwide.
Key growth drivers include advancements in molecular diagnostic technologies such as next-generation sequencing (NGS) and PCR-based assays. Expanding donor registries and government support for transplant programs are also contributing to market growth. Research in immunology and personalized medicine further strengthens the demand for precise HLA typing in clinical and research settings.
Future growth is expected to be driven by technological innovations, automation in laboratories, and increasing global transplant volumes. Emerging markets are investing in healthcare infrastructure, which will create new opportunities. Additionally, the integration of bioinformatics tools for improved data analysis will enhance testing accuracy and efficiency, supporting sustained market expansion.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Product
- Instruments
- Reagents & Consumables
- Software & Services
By Application
- Diagnosis
- Research
By Technique
- Molecular Assay
- Sequenced-based Molecular Assay
- Non-Molecular Assay
By End User
- Commercial Service Providers
- Hospitals and Transplant Centers
- Research Labs & Academic Institutes
COMPANIES PROFILED
- Thermo Fisher Scientific Inc, BioRad Laboratories Inc, Qiagen NV, Omixon Inc, GenDx, Illumina Inc, TBG Diagnostics Limited, Dickinson and Company, Takara Bio Inc, F HoffmanLa Roche Limited, Pacific Biosciences
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL HLA TYPING MARKET: BY PRODUCT 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Product
- 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Reagents & Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Software & Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL HLA TYPING MARKET: BY APPLICATION 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Application
- 5.2. Diagnosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL HLA TYPING MARKET: BY TECHNIQUE 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast Technique
- 6.2. Molecular Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Sequenced-based Molecular Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Non-Molecular Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL HLA TYPING MARKET: BY END USER 2022-2034 (USD MN)
- 7.1. Market Analysis, Insights and Forecast End User
- 7.2. Commercial Service Providers Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.3. Hospitals and Transplant Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.4. Research Labs & Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL HLA TYPING MARKET: BY REGION 2022-2034(USD MN)
- 8.1. Regional Outlook
- 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Product
- 8.2.2 By Application
- 8.2.3 By Technique
- 8.2.4 By End User
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
- 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Product
- 8.3.2 By Application
- 8.3.3 By Technique
- 8.3.4 By End User
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
- 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Product
- 8.4.2 By Application
- 8.4.3 By Technique
- 8.4.4 By End User
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
- 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Product
- 8.5.2 By Application
- 8.5.3 By Technique
- 8.5.4 By End User
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 South East Asia
- 8.5.10 Rest of Latin America
- 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Product
- 8.6.2 By Application
- 8.6.3 By Technique
- 8.6.4 By End User
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa
Chapter 9. COMPETITIVE LANDSCAPE
- 9.1. Recent Developments
- 9.2. Company Categorization
- 9.3. Supply Chain & Channel Partners (based on availability)
- 9.4. Market Share & Positioning Analysis (based on availability)
- 9.5. Vendor Landscape (based on availability)
- 9.6. Strategy Mapping
Chapter 10. COMPANY PROFILES OF GLOBAL HLA TYPING INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Company Profiles
- 10.2.1 Thermo Fisher Scientific Inc
- 10.2.2 Bio-Rad Laboratories Inc
- 10.2.3 Qiagen N.V
- 10.2.4 Omixon Inc
- 10.2.5 GenDx
- 10.2.6 Illumina Inc
- 10.2.7 TBG Diagnostics Limited
- 10.2.8 Dickinson And Company
- 10.2.9 Takara Bio Inc
- 10.2.10 F. Hoffman-La Roche Limited
- 10.2.11 Pacific Biosciences
